EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evolving role of endovascular treatment of acute ischemic stroke


Current Neurology and Neuroscience Reports 14(1): 416-416
Evolving role of endovascular treatment of acute ischemic stroke
The perceived advantages of endovascular treatment for acute ischemic stroke in terms of recanalization, the multimodal and targeted approaches, and perhaps the more permissive rules on devices than on medications for their licensing favored the assumption that endovascular treatment is superior to intravenous thrombolysis for acute treatment of ischemic stroke, and its adoption in more advanced stroke centers. However, this assumption has been questioned by recent clinical trial experience showing that endovascular treatment is not superior to intravenous thrombolysis. The new evidence has changed the perception and the importance of conducting randomized trials in this area. This summary examines the background and outcomes of the latest experience with endovascular techniques in acute stroke treatment based on historical data. The new challenge is how to study the latest generation of devices called stent retrievers, which are faster in recanalizing and easier to use, in selected patients with acute ischemic stroke. In the meantime, the available evidence does not provide support for the use of endovascular treatment of acute ischemic stroke in clinical practice.

(PDF same-day service: $19.90)

Accession: 053107213

PMID: 24258466

DOI: 10.1007/s11910-013-0416-6



Related references

Endovascular treatment for acute ischemic stroke : Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN). Der Internist 56(7): 847-850, 2016

Treatment of acute ischemic stroke: role of ischemic tolerance in intravenous and endovascular therapies. Expert Review of Cardiovascular Therapy 7(4): 331-332, 2009

Influence of Device Choice on the Effect of Intra-Arterial Treatment for Acute Ischemic Stroke in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). Stroke 47(10): 2574-2581, 2016

The role of endovascular therapy in the treatment of acute ischemic stroke. Neurosurgery 74 Suppl 1: S133-S141, 2014

Emergency management of acute ischemic stroke: the evolving roles of intravenous and endovascular therapies. JAMA Neurology 70(7): 828-830, 2013

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke 46(12): 3416-3422, 2016

Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. International Journal of Stroke 10(3): 439-448, 2016

Endovascular treatment for acute ischemic stroke using solitaire stent: temporary endovascular bypass, a novel technique. Neurology India 59(3): 401-404, 2011

A new era of endovascular treatment for acute ischemic stroke: what are the implications for stroke care in Brazil?. Arquivos de Neuro-Psiquiatria 74(1): 85-86, 2016

Futile Interhospital Transfer for Endovascular Treatment in Acute Ischemic Stroke: The Madrid Stroke Network Experience. Stroke 46(8): 2156-2161, 2015